(Q39481475)

12 September 2017

title

Antifungal susceptibilities of clinical and environmental isolates of Cryptococcus neoformans in Goiânia city, Goiás, Brazil (English)

1 reference

12 September 2017

0 references

Cryptococcus neoformans

1 reference

1 reference

Lúcia Kioko Hasimoto Souza

1

1 reference

12 September 2017

Orionalda de Fátima Lisboa Fernandes

2

1 reference

12 September 2017

Cláudia Castelo Branco Artiaga Kobayashi

3

1 reference

12 September 2017

Xisto Sena Passos

4

1 reference

12 September 2017

Carolina Rodrigues Costa

5

1 reference

12 September 2017

Janine Aquino Lemos

6

1 reference

12 September 2017

Ary Henrique Souza-Júnior

7

1 reference

12 September 2017

Maria do Rosário Rodrigues Silva

8

1 reference

12 September 2017

publication date

1 September 2005

1 reference

Revista do Instituto de Medicina Tropical de São Paulo

12 September 2017

number of pages

4

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

12 September 2017

volume

47

1 reference

12 September 2017

issue

5

1 reference

12 September 2017

page(s)

253-256

1 reference

In vitro activity of amphotericin B, fluconazole and voriconazole against 162 Cryptococcus neoformans isolates from Africa and Cambodia

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000500003

Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Australasian Cryptococcal Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000500003

Fluconazole and itraconazole susceptibility of clinical isolates of Cryptococcus neoformans at a tertiary care centre in India: a need for care

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000500003

Cryptococcus neoformans isolated from patients with AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000500003

Epidemiological aspects of clinical and environmental Cryptococcus neoformans isolates in the Brazilian state Rio Grande do Sul.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000500003

Evaluation of Etest method for determining voriconazole and amphotericin B MICs for 162 clinical isolates of Cryptococcus neoformans

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000500003

Environmental isolation of Cryptococcus neoformans var. gattii and C. neoformans var. neoformans in the city of São Paulo, Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000500003

Antifungal susceptibility of clinical and environmental isolates of Cryptococcus neoformans to four antifungal drugs determined by two techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000500003

Serotyping of 467 Cryptococcus neoformans isolates from clinical and environmental sources in Brazil: analysis of host and regional patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000500003

Environmental strains of Cryptococcus neoformans variety grubii in the city of Santos, SP, Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000500003

Cryptococcus neoformans variety gattii

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000500003

The origin and maintenance of virulence for the human pathogenic fungus Cryptococcus neoformans

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000500003

First reported isolation of Cryptococcus neoformans var. gattii from a patient in Singapore

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000500003

10.1590/S0036-46652005000500003

21 January 2018

Identifiers

DOI

1 reference

12 September 2017

1 reference